Stifel analyst W. Andrew Carter initiated coverage of Canopy Growth (CGC) with a Buy rating and C$55 price target, Aurora Cannabis (ACB) with a Hold rating and C$10 price target, Cronos Group (CRON) with a Hold rating and C$18 price target, and Tilray (TLRY) with a Hold rating and $37 price target. The analyst is bullish on the growth prospects for the cannabis industry, especially through the Canadian Licensed Producers, or LPs. Carter sees these four companies as holding a lead in the legal Canadian market, and believes they represent the "best investable opportunities in a global cannabis industry" that the firm sees reaching $200B in value. The analyst calls Canopy Growth the best opportunity, citing "definitive category leadership, C$4B cash on hand offering significant optionality, and the best position to attack the $100B U.S. opportunity."